Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndromeAntonella Tramutola, Fabio Di Domenico|Translational Neurodegeneration|2018Cited by 100
Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndromeFabio Di Domenico, Marzia Perluigi|Redox Biology|2019Cited by 67
Shaping down syndrome brain cognitive and molecular changes due to aging using adult animals from the Ts66Yah murine modelChiara Lanzillotta, Fabio Di Domenico|Neurobiology of Disease|2024Cited by 14